{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11994028", "DateCompleted": {"Year": "2002", "Month": "09", "Day": "26"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "30"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0114-5916", "JournalIssue": {"Volume": "25", "Issue": "4", "PubDate": {"Year": "2002"}}, "Title": "Drug safety", "ISOAbbreviation": "Drug Saf"}, "ArticleTitle": "A systematic review of the safety of kava extract in the treatment of anxiety.", "Pagination": {"StartPage": "251", "EndPage": "261", "MedlinePgn": "251-61"}, "Abstract": {"AbstractText": ["This paper systematically reviews the clinical evidence relating to the safety of extracts of the herbal anxiolytic kava (Piper methysticum). Literature searches were conducted in four electronic databases and the reference lists of all papers located were checked for further relevant publications. Information was also sought from the spontaneous reporting schemes of the WHO and national drug safety bodies and ten manufacturers of kava preparations were contacted. Data from short-term post-marketing surveillance studies and clinical trials suggest that adverse events are, in general, rare, mild and reversible. However, published case reports indicate that serious adverse events are possible including dermatological reactions, neurological complications and, of greatest concern, liver damage. Spontaneous reporting schemes also suggest that the most common adverse events are mild, but that serious ones occur. Controlled trials suggest that kava extracts do not impair cognitive performance and vigilance or potentiate the effects of central nervous system depressants. However, a possible interaction with benzodiazepines has been reported. It is concluded that when taken as a short-term monotherapy at recommended doses, kava extracts appear to be well tolerated by most users. Serious adverse events have been reported and further research is required to determine the nature and frequency of such events."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Complementary Medicine, University of Exeter, Exeter, United Kingdom."}], "Identifier": [], "LastName": "Stevinson", "ForeName": "Clare", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Huntley", "ForeName": "Alyson", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ernst", "ForeName": "Edzard", "Initials": "E"}], "PublicationTypeList": ["Journal Article", "Meta-Analysis", "Research Support, Non-U.S. Gov't", "Systematic Review"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Drug Saf", "NlmUniqueID": "9002928", "ISSNLinking": "0114-5916"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Anxiety Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "3K9958V90M", "NameOfSubstance": "Ethanol"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Anxiety Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Anxiety"}, {"QualifierName": [], "DescriptorName": "Chemical and Drug Induced Liver Injury"}, {"QualifierName": [], "DescriptorName": "Drug Interactions"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ethanol"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Kava"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Myoglobinuria"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Nervous System Diseases"}, {"QualifierName": [], "DescriptorName": "Neuropsychological Tests"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["adverse effects", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Product Surveillance, Postmarketing"}, {"QualifierName": [], "DescriptorName": "Psychomotor Performance"}, {"QualifierName": [], "DescriptorName": "Randomized Controlled Trials as Topic"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Skin Diseases"}, {"QualifierName": ["drug effects"], "DescriptorName": "Sleep"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Hautarzt. 1996 Jun;47(6):459-61", "ArticleIdList": ["8767662"]}, {"Citation": "Med J Aust. 1997 Aug 4;167(3):172-3", "ArticleIdList": ["9269278"]}, {"Citation": "Br J Clin Pharmacol. 1998 May;45(5):496-500", "ArticleIdList": ["9643624"]}, {"Citation": "Prog Neuropsychopharmacol Biol Psychiatry. 1998 Oct;22(7):1105-20", "ArticleIdList": ["9829291"]}, {"Citation": "Neurol Sci. 2000 Apr;21(2):124", "ArticleIdList": ["10938194"]}, {"Citation": "Arzneimittelforschung. 1991 Jun;41(6):584-8", "ArticleIdList": ["1930344"]}, {"Citation": "J Am Acad Dermatol. 1998 Jan;38(1):104-6", "ArticleIdList": ["9448214"]}, {"Citation": "Drug Alcohol Rev. 1993;12(1):49-57", "ArticleIdList": ["16818312"]}, {"Citation": "Drug Alcohol Rev. 1997 Jun;16(2):147-55", "ArticleIdList": ["16203421"]}, {"Citation": "Pharmacopsychiatry. 1994 Nov;27(6):224-30", "ArticleIdList": ["7870743"]}, {"Citation": "J Am Acad Dermatol. 1994 Jul;31(1):89-97", "ArticleIdList": ["8021378"]}, {"Citation": "Fortschr Med. 1991 Feb 10;109(4):119-22", "ArticleIdList": ["2029982"]}, {"Citation": "Blutalkohol. 1993 Mar;30(2):96-105", "ArticleIdList": ["8481222"]}, {"Citation": "BMJ. 2001 Jan 20;322(7279):139", "ArticleIdList": ["11159570"]}, {"Citation": "J Clin Rheumatol. 1999 Dec;5(6):342-5", "ArticleIdList": ["19078427"]}, {"Citation": "J Clin Psychopharmacol. 2000 Feb;20(1):84-9", "ArticleIdList": ["10653213"]}, {"Citation": "Munch Med Wochenschr. 1970 Jan 23;112(4):154-8", "ArticleIdList": ["5537653"]}, {"Citation": "Med J Aust. 1988 Sep 19;149(6):341-2", "ArticleIdList": ["3419385"]}, {"Citation": "MMW Munch Med Wochenschr. 1974 Apr 5;116(14):741-2", "ArticleIdList": ["4151726"]}, {"Citation": "Neuropsychobiology. 1993;27(1):46-53", "ArticleIdList": ["8515824"]}, {"Citation": "Contact Dermatitis. 2000 Jun;42(6):363-4", "ArticleIdList": ["10871112"]}, {"Citation": "Dtsch Med Wochenschr. 1998 Nov 20;123(47):1410-4", "ArticleIdList": ["9856112"]}, {"Citation": "Med J Aust. 1988 Jun 6;148(11):548-55", "ArticleIdList": ["3374423"]}, {"Citation": "N Z Med J. 2000 Jul 28;113(1114):315-7", "ArticleIdList": ["10972312"]}, {"Citation": "Ann Intern Med. 1996 Dec 1;125(11):940-1", "ArticleIdList": ["8967683"]}, {"Citation": "Lancet. 1998 Oct 24;352(9137):1331-6", "ArticleIdList": ["9802269"]}, {"Citation": "Pharmacopsychiatry. 1997 Jan;30(1):1-5", "ArticleIdList": ["9065962"]}, {"Citation": "Ann Intern Med. 2001 Jul 3;135(1):68-9", "ArticleIdList": ["11434754"]}, {"Citation": "J Neurol Neurosurg Psychiatry. 1995 May;58(5):639-40", "ArticleIdList": ["7745421"]}, {"Citation": "Minerva Ginecol. 2000 Jun;52(6):263-7", "ArticleIdList": ["11085051"]}]}], "History": [{"Year": "2002", "Month": "5", "Day": "8", "Hour": "10", "Minute": "0"}, {"Year": "2002", "Month": "9", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2002", "Month": "5", "Day": "8", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11994028", "10.2165/00002018-200225040-00003", "250403"]}}], "PubmedBookArticle": []}